3.500
−14,63%
2026-10-13
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -816.6% | -175.7% | 2 / 3 | +151.1% | -1.86 pp | -0.37 pp | +2.1% | 0.00 | 65.36 | 3.403 | +151,1% | −9,3 | −833,2% | 65.36 | 113.08 | −42,2% |
| Pts | 0 | 0 | 8 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 3.500 (close price on 2026-10-13)EPS (TTM): 53,5
Financial charts
1.Revenue & growth
VND bn3.403Q2/26
1.Revenue & growth
VND bn3.403Q2/26
2.Profit & growth
VND bn-9,32Q2/26
3.Profit mix (Penman)
VND bn13,4Q2/26
4.Margins & cost structure
%3.8%Q2/26
5.Returns & cash cycle
% · days0.8%Q2/26
6.Earnings quality & cash
VND bn81,1Q2/26
7.Asset structure
VND bn1.380Q2/26
8.Funding & debt health
VND bn · times1.380Q2/26
9.Revenue backlog
VND bn8,39Q2/26
10.Valuation
times · %65,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-37Q2/26
Adjusted EPS growth, latest quarter
-817%
Average adjusted EPS growth, 3 quarters
-817%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26